Posters: CSV26: 6th Symposium of the Canadian Society for Virology

Breaking & Entering

Name	Presenter
A Cross-Species Framework for Clustering H3NX Influenza A Hemagglutinin Nucleotide Sequences	Hoc Tran,University of Guelph
Characterization of a Novel Neuraminidase Stalk Deletion in Highly Pathogenic Avian Influenza Clade 2.3.4.4b A(H5N5) Strains Isolated in Atlantic Canada	Tracy Shutao Xie, University of Ottawa
Delineating the role of DC-SIGN during Ebola virus entry: A critical host factor that promotes macropinocytosis	Soniya Agarwal, University of Ottawa
Ebola virus trafficking factor PIKfyve-VAC14-FIG4 complex assembly is regulated by calmodulin binding	Agnitha Xavier, University of Ottawa
Evidence of Crimean-Congo hemorrhagic fever seroprevalence in hunter-gatherers' pygmy community in North-eastern DRC	Dacquin M. Kasumba, Institut National de Recherche Biomédicale
Identification of Cellular Receptors for African Swine Fever Virus	Kaitlyn Blundon, University of Guelph
Identifying the Emv2-derived endogenous retroviral receptor in mouse vaginal tissue	W. Austin Guild, University of British Columbia
Influenza Virus Receptor Distribution and Hemagglutinin Binding in Tissues of Various Species to Define Susceptibility to H5N1 Infection in Wildlife, livestock, and companion animals in Canada	Akila Kularatne, University of Calgary
Investigating H5N1 highly pathogenic avian influenza entry into human respiratory cells and the role of sialic acid	Abbey J. McMurray, Queen's University

Building & Escaping

Name	Presenter
Applying Flow Virometry to Distinguish Extracellular Vesicles from Viral Particles	Deepa Chaphekar, University of Toronto, Scarborough
A stable, virus-free A549 reporter system to quantify respiratory syncytial virus NS2 antagonism of interferon beta promoter activation	Elina Gerber-Tichet, Université de Montréal
Coronavirus membrane proteins disperse the trans-Golgi network and inhibit anterograde protein trafficking in the secretory pathway	Craig McCormick, Dalhousie University
Host Interactome of the Measles Virus Matrix Protein Provides an Avenue for Drug Repurposing	Benjamin Beavington, University of Toronto
Influenza A virus hijack of the autophagy machinery for viral budding	Andrew Leidal, University of Calgary
Investigating the maturation of SARS-CoV-2 Spike glycans during viral egress	Wenjing Zhang, McGill University
Primary envelopment of Kaposi's sarcoma-associated herpesvirus at the nucleoplasmic reticulum	Alexa Wilson, Dalhousie University
Reovirus utilizes microtubules to coordinate core versus whole virus assembly	Dante Terino, University of Alberta
Staphylococcus aureus lipases enhance influenza A virus replication by remodeling host cell lipids	Karen Nickel, University of Victoria

Damaging & Spreading

Name	Presenter
Characterization of Infection and Programmed Cell Death during Poxvirus-induced Pregnancy Complications: Molecular Mechanisms and Pathogenesis	Hannah Wallace, University of Manitoba
Comparison of SARS-CoV-2 Variant Pathogenicity in a Long-COVID Syrian Hamster Model	Maya Naghibosadat, Sunnybrook Research Institute/ University of Toronto
Integrating qPCR Diagnostics and Genomic Surveillance for Real-Time Characterization of MPXV Clade Dynamics in Sierra Leone's 2025 Outbreak.	Michaella Jaba, Univeristy Of Manitoba
Respiratory syncytial virus induces caspase-1 and GSDMD-mediated airway epithelial cell pyroptosis	Runqi Lin, University of Manitoba
Sex hormone modulation of oncolytic Vesicular stomatitis virus enhances breast cancer virotherapy	Marie-Claude Bourgeois-Daigneault, CRCHUM, University of Montreal
The globalization of the Clade Ib/sh2023 Mpox virus: tracking the evolutionary pattern of sustained human-to-human transmission	Anuj Kumar, Dalhousie University, Halifax, Canada
Unraveling the Genetic Factors Influencing Susceptibility and Resistance to Viral Myocarditis	Zhihan Wang, University of British Columbia
ZIKV infection reshapes progenitor and neuronal cell states in developing zebrafish brain, implicating altered commitment signatures	Yago Gomes, Institut National de la Recherche Scientifique

Discovering & Evolving

Name	Presenter
A Biosafe and Flexible Human Adenovirus Type 4 Viral Vector Platform for Rapid H5N1 Vaccine Development and Pandemic Preparedness	Nausin Tasnim, University of Manitoba
A lactating goat surrogate model for H5N1 influenza virus infection and vaccine efficacy in dairy cows	Lauren Aubrey, University of Saskatchewan
American crow (Corvus brachyrynchos) Orthoreovirus neoavis strain diversity across Canada	Marie-Jeanne Pesant, Université de Montréal
Assessing the Impact of Superinfection and Recombination on Phylodynamics Inference by Multi-Level Simulation	Delicia Wong, Western University
Case presentation of patients hospitalised with mpox (subclade Ib/2023sh) including children, adolescents, and adults in South Kivu, Democratic Republic of the Congo: an observational cohort study	Gustavo Sganzerla Martinez, Dalhousie University
Characterizing the accessory proteins in novel rodent Embecoviruses	Eduardo Suarez Lopez, University of Toronto
Conducting Field Studies to Estimate the Prevalence of Hantavirus Infection in Wild Deer Mouse Populations in Saskatchewan	Vidhi Vakharia, University of Saskatchewan
Defining the VP40 - Host Interactome in Filovirus: Differential Remodeling by Nucleoprotein and Glycoprotein	Mariam DAO, Ottawa University
Detection of High-Risk HPV Genotypes and Circulating E6/E7 Oncoproteins in Colorectal Cancer	Mahsa Javadi, Tehran University of Medical Sciences
Development and validation of functional assays for measuring neutralizing antibodies to H5N1 influenza A virus hemagglutinin and neuraminidase in a wide range of species and sample types.	Abdulla Shuhait, Dalhousie University
Development of a Chimeric Lassa Virus Glycoprotein Library Using DNA Shuffling for Broadly Reactive Vaccine Antigen Discovery	Chandra Bose Prabaharan, University of saskatchewan
Elucidating how high-risk A1762T/G1764A mutations alter HBx function to promote liver cancer	Clare Gilmour, University Of Alberta
Establishing a rapid and safe genotype-to phenotype platform to characterize circulating highly pathogenic avian influenza strains	Claudia Santos Saenz, University of Ottawa
Evolutionary fingerprinting of protein-coding genes in RNA viruses	Hugo Gildardo Castelán Sánchez, Western University
Evolution of a truncated nucleocapsid protein enhances SARS-CoV-2 fitness by suppressing antiviral responses	Rory Mulloy, University of Calgary
Expanding the toolbox: an aptameric approach investigating new targets for inhibiting Influenza's viral polymerase	Mary Hernando, University of Alberta
Fowl Aviadenovirus (FAdV) Genomic Diversity in Poultry Diagnostic Liver Samples Collected From 2019 to 2024 in Quebec, Canada	Marika Koszegi, Université de Montréal
From surveillance to preparedness: Mapping arbovirus circulation across Canadian and Arctic ecosystems	Jumari Snyman, University of Alberta
Genomic epidemiology of paramyxoviruses from a two-year surveillance study at a tertiary care academic hospital	Kayla Gaete, Sunnybrook Health Sciences Centre
Hepatoprotective, Antioxidant, Anti-Inflammatory Effects of Silymarin in Yellow Fever Virus Infected Hepg2 cells and AG129 mice	Oluwashola Samuel Olaolu, Federal university of Ouro preto
Host Finder: computational detection of virus-host interactions by large-scale data-mining of the Sequence Read Archive	Shyan Mascarenhas, University of Waterloo
Interferon beta specificity in humans and bats contributes to differences in viral replication and tolerance	Rita Maria Quintela Tizon, Vaccine and Infectious Disease Organization / University of Saskatchewan
Investigating the Role of WNK Signaling in Viral Replication	Matthew Melki, McMaster University
Investigating the Susceptibility of Canadian Wildlife and Livestock Species to MPXV Infection Using Organoid Models	Ayoub Mebarki, University of Calgary
Isolation and Molecular Characterization of West Nile Virus Circulating in Wild Bird Populations in Quebec	Anais Rasquier Zevallos, INRS
Lessons from Viral RNAs: Strategies to Improve Therapeutic mRNA Stability	Hedieh Hashemi, University of British Columbia
Modifications in the sialic acid binding domain of reovirus binding protein can increase cell attachment	Spencer Luong, University of Alberta
Orthopoxvirus serological responses among key populations in Manitoba and Alberta, Canada: A seroprevalence studyOrthopoxvirus serological responses among key populations in Manitoba and Alberta, Canada: A seroprevalence study	Elise Gork, University of Manitoba
Quantitative Flow Virometry Approaches for High Yield Sorting of Virus Particles	Claire Fernandes, University of Toronto
Resolving HIV-1 Transmission Risk Structure in Genetic Clusters with Community Detection	Paula Magbor, Western University
Seasonal spike evolution in human Coronavirus OC43 arises with and without immune pressure	Kyla Tozer, University of Toronto
Sero-Molecular Epidemiology of HBV and TB in HIV-Positive Patients on Antiretroviral Therapy in Port Harcourt, Nigeria	Onoriode Okpako Diamreyan, University of port harcourt, rivers state, nigeriaa
Structures of hemagglutinin (HA) for understanding the human infectivity of H5N1 Influenza A	Ross A. Edwards, University of Alberta
The Application of Synthetic Nanobodies to Investigate Secondary Envelopment of HSV-2 Nucleocapids	Addisyn G. Smith, Queen's University
treeswithintrees: an R package for simulating transmission histories and virus phylogenies	Art Poon, Western University
Understanding the conformation dynamics of E2 protein in HCV neutralization	Derek Cheung, Memorial University of Newfoundland
Unravelling the "dark matter" of cyanophages: from protein structure to function	Jozef Nissimov, University of Waterloo
Viral diversity and virus-host associations in the neovaginal microbiome of transfeminine individuals	Jorge Rojas-Vargas, University of Western Ontario
Virological expedition in representative ecosystems of Colombia: tropical rainforest of the Sierra Nevada de Santa Marta	Katherine Laiton-Donato, Instituto Nacional de Salud
When Orthobornaviruses Collide: Interference and Co-Persistence in Cell Culture	Praveen Akmeemana, University of Guelph

Expressing & Multiplying

Name	Presenter
ACE2 Receptor Expression Kinetics in CD4⁺ T Cells Following HCoV-NL63 Infection	Negar Joharinia, university of Ottawa
A non-coding RNA from Kaposi's sarcoma-associated herpesvirus (KSHV) restructures cellular nuclear speckles (NSs) for optimal viral replication	Jill Allmendinger, University of Calgary
Augmenting Newcastle Disease Virus Oncolytic Potency Through Combined Mutations in the F and HN Genes	Alyssa Bogle, University of Guelph
Characterizing Mayaro virus protein interactome in the context of infection.	Joaquin Lopez-Orozco, University of Alberta
Characterizing Subgenomic RNA Expression and Replication Strategies of Grapevine Rupestris Stem-Pitting Associated Virus	Maya Abboud, University of Guelph
Defining HPV E7 impact on the functions of the E3-ubiquitin ligase RNF168 at stalled replication forks.	Ottilie Le Doeuff, Université Laval
Determining the role of NS2A-associated host factors in flavivirus replication	Jayden Harris, Emory University
Development and Characterization of a Sudan Virus Minigenome System	David Lu, University of Manitoba
Development of a Reporter-Based Replicon System to Study Human Norovirus Replication	Bridgett Sparkes, Memorial University of Newfoundland
Effect of Mutations in the Polymerase Basic Protein 2 of Highly Pathogenic Avian Influenza on Adaptation, RNA synthesis and Drug Susceptibility	Adrien Delpal, University of Alberta
Establishment of an Improved SARS-CoV-2 Replicon Particle Platform for Functional Studies	Danni Yong, McGill University
G4-quadruplex, secondary structure controlling HBV pre-Core promoter expression: Defining structure and function using mutational, computational and proteomic studies	Kira Sviderskaia, University of Alberta
HIV reservoir and plasma rebound dynamics in context of HIV superinfection	Fredrick Harrison Omondi, Simon Fraser University
Homotypic endoplasmic reticulum membrane tethering is critical for flavivirus replication	Jonathan Owen, Emory University
How do bacterial induced changes in host membrane lipid composition affect influenza replication?	Megan VanderWal, University of Victoria
IGF2BP2: A role in the replication cycle of Zika virus	Yann Desfossés, Institut national de la recherche scientifique
Investigating the role of RNA helicases in the life cycle of Old-World Alphaviruses	Carmen Agenbacht, University of Lethbridge
Mechanistic Analysis of Argonaute 2 and miR-122 Promotion of Hepatitis C Virus Replication and Translation	Michael A. Palmer, University of Saskatchewan
Mechanistic Insights into NS5 Translocation During Flaviviral Negative-Strand RNA Synthesis	Scott Tersteeg, University of Lethbridge
Non‑coding viral regulatory elements drive differential transcript and protein expression of SARS‑CoV‑2 accessory genes to inhibit antiviral responses	Arkadeb Bhuinya, Vaccine and Infectious Disease Organization, University of Saskatchewan
Non-suppressible HIV viremia sustained by clonally expanded CD4+ T-cells harboring a genomically defective provirus with an immune-evasive protein expression profile	Fredrick Harrison Omondi, Simon Fraser University
ORF57 enables SOX-dependent host shutoff to support accumulation of the KSHV lytic proteome	Eric Pringle, Dalhousie
Primary Airway Cells Recapitulate Healthy but not Asthma-Associated Responses to Rhinovirus in Humans	Cameron Griffiths, University of Virginia
Replication Kinetics and viral determinants of H5N1 Highly pathogenic avian influenza infection in human airway cells	Nidhi Kaushik, Vaccine Infectious Disease Organization
Structure-Guided Discovery of Low-Nanomolar Influenza A PB2 Cap-Binding Inhibitors	Ahmed Oraby, University of Alberta
The Epstein-Barr virus protein BMRF1 recruits the host NuRD complex to promote viral lytic genome replication.	Beata Cohan, University of Toronto
The HSV-2 Viral Kinase pUs3 Interacts with the Viral Protein VP11/12 During Infection	Ethan Thomas, Queen's University
The "Iceberg" Region of the Grapevine leafroll-associated virus 3 Replicase Polyprotein Directs Mitochondrial Targeting to Promote Viral Replication	Catherine Fust, University of Guelph
The Role of HSV-2 pUL16 in Altering Host Cellular Energy Metabolism	Nick Denniston, Queens University
Uncovering Early Coronavirus Replication Events through Strand-Specific RNA Analysis and Host–Virus Complex Localization	Ahmed Eisa Elhag, Institute of Biochemistry and Biophysics, Polish Academy of Science
Virome based discovery, and investigation of IRES-driven alternative reading frame translation	Subash Chapagain, UBC Jan Lab

Fighting & Responding

Name	Presenter
A High Throughput Serology and Molecular Diagnostics Platform for Population Level Surveillance of Respiratory Infections	Shirley Qiu, University of Ottawa
An In-house Reverse Genetic System to Study the Infectious Pancreatic Necrosis Virus Viral Protein 3	Liyuan Liu, University of Toronto
A Novel CD103 Expression Profile in Macrophages Following Endosomal Viral Sensing	Nasry Zane Bouzeineddine, Queen's University
Anti-drug antibody responses to AAV-mediated monoclonal antibody expression in a sheep model	Erin Howard, University of Guelph
Assessment of influenza A cap-binding inhibitors and mechanisms of resistance	Arlo Loutan, University of Alberta
Assessment of Pan-Sarbecovirus neutralizing antibody activity in sera from vaccinated and SARS-CoV-2 infected Canadian individuals	Arianna Hurtado Monzon, VIDO, University of Saskatchewan
Beyond Interferon: A New Model for Long Double-Stranded RNA in Antiviral Defense	Stephanie DeWitte-Orr, Wilfrid Laurier University
Broadly-neutralizing IgA requires Fc-Fc-receptor interaction for optimal protection against influenza A virus infection	Yona Tugg, McMaster University
Characterization of canonical and non-canonical antiviral responses in white-tailed deer cells infected with host-adapted SARS-CoV-2	Sophie-Marie Aicher, University of Toronto
Comparing next-generation HLA-class-I-matched humanized mouse models for investigating the efficacy of oncolytic BHV-1 virotherapy in pancreatic ductal adenocarcinoma	Madeleine Lepard, McMaster University
Contributions of Human Coronavirus NL63 Viral Proteins to ACE2 Cell-Surface Dynamics	Caroline Silveira Falleiros Silva, University of Ottawa
CRISPR-RfxCas13d-Mediated Antiviral Therapeutic Against Venezuelan Equine Encephalitis Virus RNA-Dependent RNA-Polymerase	Michael H. D'Souza, University of Lethbridge
Cross Neutralizing Antibody Responses to Emerging HPAI H5 Clade 2.3.4.4b Viruses	Oluwafemi Adu, University of Alberta
Cryo-EM Platform for Targeting the RNA Polymerase of Respiratory Viruses	Calvin J. Gordon, University of Alberta
DDX21-Mediated Antiviral State Protects Against HSV-2 in Vaginal Epithelial Cells	Lauren Jirik, McMaster University
Determining the Impact of Non-Subtype B Nef-Mediated SERINC5 Downregulation on Latent Reservoir Dynamics in People Living with HIV-1 on ART	Livia Kucman, Western University
Development of a platform for vectorized expression of secretory IgA at mucosal surfaces for prevention of Pseudomonas aeruginosa infections.	Benjamin Manchester, University of Guelph
Development of upper respiratory tract 2D cellular models of wildlife and livestock species to study host responses to highly pathogenic avian influenza viruses	Celine Tan, University of Toronto
Digitally Immune-Optimised Next-Generation Influenza Vaccine Provides Cross-Clade Protection Against Challenge With Lethal H5N1 Viruses Challenge in Mice	Rose Chan, Public Health Agency of Canada
Establishing an Insectivorous Bat Model to Study MERS-CoV Infection Dynamics, Immune Responses and Viral Persistence	Kaushal Baid, University of Saskatchewan
Evaluating the protective immunity of subunit vaccine candidates against monkeypox virus infection in mice	Kathleen Fulton, University of Manitoba
Exploring cross-subtype serological responses against avian H5Nx	Katrina Dionne, Université de Montréal
Expression of Immune-Related Genes in the Brains of Chickens Experimentally Infected by Aquatic Bird Bornavirus 1	Igor R. Santos, University of Guelph
Extended IL-4 priming of macrophages induces an antiviral state that restricts Lymphocytic Choriomeningitis Virus replication.	Julia Barilo, Queen's University
Hacking the innate immune system; tunable phytoglycogen nanoparticles for the delivery of long dsRNA for antiviral applications	Stephanie DeWitte-Orr, Wilfrid Laurier University
High-content flow cytometric comparison of immune responses following administration of SARS-CoV2 Spike (S) protein via viral vector and mRNA vaccine platforms	Julia May, University of Alberta
Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functions	Krithika Muthuraman, The Hospital for Sick Children
Human DPP4 Mouse Model of MERS-CoV reveals differential Lung and Brain Viral Kinetics	Tekeleselassie Ayalew Woldemariam, VIDO, University of Saskatchewan
Immunogenicity and efficacy of a Newcastle disease virus vectored vaccine against highly pathogenic avian influenza in poultry and mammals	Alex Leacy, University of Guelph
Immunogenicity and Efficacy of an mRNA Vaccine Encoding Hemagglutinin (HA) and Neuraminidase (NA) of H9N2 Avian Influenza Virus in Chickens	Fatemeh (Darya) Fazel, University of Guelph
Improving Fc-effector functions of a potent anti-S2 pan-coronavirus antibody for pandemic preparedness	Katrina Dionne, Université de Montréal
Inactivation Approaches for Highly Pathogenic Avian Influenza Virus Enabling Safe CL-2 Laboratory Practice	Natalia Pessoa, VIDO/University of Saskatchewan
Inhibition of neuraminidase of highly pathogenic avian influenza A viruses	Bryson Hammer, University of Alberta
Initial Insights into How Vaccination Route Shapes Survival	Juliette Bougon, University of Alberta
Intranasal delivery of low dose long dsRNA protects against SARS-CoV2 in Syrian hamsters	Dominique Daniels, Wilfrid Laurier University
Investigating the role of the unfolded protein response and SERCA inhibition in the antiviral activity of Thapsigargin against human coronaviruses.	Debanjana Mondal, Queen's University
Itaconate is induced by oncolytic VSV infection and limits viral replication in tumor cells	Dominic Roy, Centre de Recherche du CHUM/Université de Montréal
Iterative rational design of a ferritin pan–group 1 influenza nanoparticle vaccine informed by immune feedback and mechanistic analysis of cross reactivity	Kawkab Kanjo, University of Calgary
Mechanisms of dsRNA-Mediated Antiviral Immunity in a Comparative Model	Meghan Soares, Wilfrid Laurier University
Microproteins Can Modulate the Type I Interferon Response	Justin Klassen, University of Saskatchewan
Mpox Virus (MPXV) Surveillance in Regions of Central Africa at a One Health Animal-Human Interface	Christina Frederick, University of Manitoba
Mucosally-derived secretory IgA provides broad protection against influenza A virus	Yona Tugg, McMaster University
Multivalent New World Hantavirus Vaccine Candidate Design and Development Using Integrated Structural Biology	Sourabh Suran, University of Saskatchewan
Optimizing the design of a virus-like particle-based vaccine against herpes simplex virus type 2	Vanny Pornsinsiriruk, University of British Columbia
Peroxiredoxin-1 and -2 tune MAVS-dependent antiviral signaling	Harake A., CHUM Research Center
Population immunity to measles infection in Edmonton: a cross-sectional survey of seroprevalence and T cell immunity	Kira Sviderskaia, University of Alberta
Preclinical safety and tolerability of an AAV vector expressing TLR9 as an adjuvant therapy	Cici Yang, University of Guelph
Predictive Antibody Modeling for Emerging Pathogens: Integrating Machine Learning with High Throughput Experimental Pipelines	Nicholas Coates, University of Ottawa
Role of Endogenous Apolipoprotein B mRNA Editing Enzyme Catalytic Subunit 3 (APOBEC3) in clade IIb mpox virus evolution and host responses to mpox virus infection.	Oluwaseyi Ajagbe, Vaccine for Infectious Disease Organization/ University of Saskatchewan
SAMD9L is a restriction factors that directly inhibits the translation of flaviviruses	Marion Cannac, Centre Armand Frappier Santé Biotechnologie (INRS)

Suppressing & Conquering

Name	Presenter
AAV-mediated expression of a bispecific antibody provides pan-filovirus protection in lethal Ebola and Marburg challenge models	Elena Campbell, University of Guelph
Activation of Toll-like receptor 4 by dengue virus NS1 contributes to the antiviral response	Che Colpitts, Queen's University
Analysis of Eastern Equine Encephalitis Virus NSP1 Protein's Interaction with Cellular vATPase Complex	Eve Simpson, University of Saskatchewan
ARGLU1 is a Negative Regulator of the Adenoviral Replicative Cycle	Amit Koul, Univeristy of Manitoba
Balancing Immune Evasion and Host Control: Eptesipox Virus Infection Across Bat and Human models	Hannah Mahoney, University of Saskatchewan
Biodistribution and Shedding of a Newcastle Disease Virus Vaccine Vector in Poultry and Mammals	Praveen Akmeemana, University of Guelph
Characterization of an HHV-6A Immediate-early 1 Mutant Deficient in the Inhibition of DNA Break Repair	Noémie Rochon, Centre de recherche du CHU de Québec - Université Laval
Characterization of Epstein-Barr Virus LF1 protein and its role in manipulating mRNA export.	Jasmine Sheppard, University of Toronto
Characterizing Endolysosomal Trafficking of SERINC5 During Downregulation by HIV-1 Nef	Alexandra Glennie, Western University
CLKing HIV On or Off: A key role for SR kinases in the control of HIV-1 latency	Alan Cochrane, University of Toronto
Escape from SARS-CoV-2 Nsp1-mediated host shutoff is determined by sequence features 10-18 nucleotides from the 5' end of mRNA	Denys Khaperskyy, Dalhousie University
Exploring the Cellular Interactions of H5Nx Influenza NS1 in Human and Avian Cells	Brooklyn Osborne, University of Alberta
Human cytomegalovirus microRNAs miR-US5-2 and miR-US25-2 target the Wnt pathway protein Dvl3 to regulate latent infection in CD34+ hematopoietic progenitor cells	Meaghan Hancock, University of Guelph
Identification of the minimal features required for dsRNA binding by the human coronavirus 229E nucleocapsid protein	Madeline Day, University of Calgary
In silico modelling of primary and chimeric HIV-1 Vpu proteins to complement in vitro functional assays	Mitch Mumby, Western University
Interferon Lambda Protects Bronchial Epithelial Cells Against House Dust Mite-Enhanced Respiratory Syncytial Virus Infection	Wilfred Gitau, University of Manitoba
Investigating the mechanism of PKR antagonism by hepatitis C virus NS5A: A comparative study	Carla Gallardo Flores, Queen's University
KSHV kaposin is a bifunctional RNA that employs a dual mechanism to mediate processing body disassembly	Maxwell Bui-Marinos, University of Calgary
Mechanisms of Host Innate Immune Suppression by HAdV-C5 and Human Ubiquitin E3 Ligase UBR4	Lauren Fulham, University of Manitoba
Modelling and Testing Anti-HIV-1 Immune Responses to Mutant-Env VSV-Vector Vaccines	Alexander Gain, University of Western Ontario
Modulation of the RIG-I dependent IFNβ response by Highly Pathogenic Avian Influenza H5N1 virus NS1 protein	Leslie Macas, University of Saskatchewan
Novel Roles of an Epstein-Barr Virus Protein in Post-transcriptional RNA Regulation	Ashley Campbell, University of Toronto
Role of variant-specific SARS-CoV-2 non-structural accessory proteins in host-pathogen interactions	Amir Rooddehghan, University of Saskatchewan/VIDO
SARS-CoV-2 infections alters mitochondria morphodynamics and heterotypic organelle contacts via ORF viral proteins	Mathilde Broquiere, INRS - Centre Armand-Frappier Santé Biotechnologie
Sex Hormone Mediated MicroRNA Regulation in Vaginal Epithelial Cells and its Impact on HIV Susceptibility	Shreya Joshi, McMaster University
Susceptibility and permissiveness to mpox virus	Rajesh Jacob, McMaster University
Targeting PEDV G1b and G2b Variants with a Single Bivalent Subunit Vaccine	Shreya Sharma, VIDO, University of Saskatchewan
The human cytomegalovirus chemokine binding protein UL22A is necessary for efficient reactivation from latency in CD34 + hematopoietic progenitor cells and humanized mice.	Meaghan Hancock, University of Guelph